Matching articles for "PCV 7"
Adult Immunizations
The Medical Letter on Drugs and Therapeutics • December 1, 2011; (Issue 112)
Vaccines recommended for routine use in US adults
are reviewed here. Vaccines for travel have been
reviewed...
Vaccines recommended for routine use in US adults
are reviewed here. Vaccines for travel have been
reviewed separately.
An Expanded Pneumococcal Vaccine (Prevnar 13) for Infants and Children
The Medical Letter on Drugs and Therapeutics • August 23, 2010; (Issue 1345)
The FDA has licensed a 13-valent conjugate pneumococcal vaccine (PCV13; Prevnar 13 – Pfizer) for
the prevention of invasive pneumococcal disease (IPD) in infants and children...
The FDA has licensed a 13-valent conjugate pneumococcal vaccine (PCV13; Prevnar 13 – Pfizer) for
the prevention of invasive pneumococcal disease (IPD) in infants and children <6 years old. It replaces
Prevnar (PCV7). An unconjugated 23-valent polysaccharide vaccine (PPSV23; Pneumovax 23 – Merck) is FDA-approved for use in adults.